Literature DB >> 21366859

Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis.

L M Kucirka1, H Sarathy, P Govindan, J H Wolf, T A Ellison, L J Hart, R A Montgomery, R L Ros, D L Segev.   

Abstract

The OPTN defines high risk donors (HRDs), colloquially known as 'CDC high risk donors', as those thought to carry an increased risk of HIV window period (WP) infection prior to serologic detectability. However, the true risk of such infection remains unknown. To quantify the risk of WP infection in each HRD behavior category, we performed a systematic review and meta-analysis of studies of HIV prevalence and incidence. Of 3476 abstracts reviewed, 27 eligible studies of HIV infection in HRD populations were identified. Pooled HIV incidence estimates were calculated for each category of HRD behavior and used to calculate the risk of WP HIV infection. Risks ranged from 0.09-12.1 per 10 000 donors based on WP for ELISA and 0.04-4.9 based on nucleic acid testing (NAT), with NAT reducing WP risk by over 50% in each category. Injection drug users had the greatest risk of WP infection (4.9 per 10 000 donors by NAT WP), followed by men who have sex with men (4.2:10 000), commercial sex workers (2.7:10 000), incarcerated donors (0.9:10 000), donors exposed to HIV through blood (0.6:10 000), donors engaging in high-risk sex (0.3:10 000) and hemophiliacs (0.035:10 000). These estimates can help inform patient and provider decision making regarding HRDs. ©2010 The Authors Journal compilation©2010 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21366859      PMCID: PMC3110509          DOI: 10.1111/j.1600-6143.2010.03329.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  61 in total

1.  Provider utilization of high-risk donor organs and nucleic acid testing: results of two national surveys.

Authors:  L M Kucirka; R Namuyinga; C Hanrahan; R A Montgomery; D L Segev
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

2.  Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs.

Authors:  L M Kucirka; C Alexander; R Namuyinga; C Hanrahan; R A Montgomery; D L Segev
Journal:  Am J Transplant       Date:  2009-02-03       Impact factor: 8.086

3.  Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

4.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

5.  Provider response to a rare but highly publicized transmission of HIV through solid organ transplantation.

Authors:  Lauren M Kucirka; R Lorie Ros; Aruna K Subramanian; Robert A Montgomery; Dorry L Segev
Journal:  Arch Surg       Date:  2011-01

6.  Traveling young injection drug users at high risk for acquisition and transmission of viral infections.

Authors:  Judith A Hahn; Kimberly Page-Shafer; Jamye Ford; Alan Paciorek; Paula J Lum
Journal:  Drug Alcohol Depend       Date:  2007-11-05       Impact factor: 4.492

Review 7.  The high-risk donor: viral infections in solid organ transplantation.

Authors:  Andrew L Singer; Lauren M Kucirka; Ruth Namuyinga; Colleen Hanrahan; Aruna K Subramanian; Dorry L Segev
Journal:  Curr Opin Organ Transplant       Date:  2008-08       Impact factor: 2.640

8.  HIV prevalence and associated risk behaviors in New York City's house ball community.

Authors:  Christopher S Murrill; Kai-Lih Liu; Vincent Guilin; Edgar Rivera Colón; Laura Dean; Lisa A Buckley; Travis Sanchez; Teresa J Finlayson; Lucia V Torian
Journal:  Am J Public Health       Date:  2008-04-29       Impact factor: 9.308

9.  The Cedar project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities.

Authors:  Patricia M Spittal; Kevin J P Craib; Mary Teegee; Catherine Baylis; Wayne M Christian; A K M Moniruzzaman; Martin T Schechter
Journal:  Int J Circumpolar Health       Date:  2007-06       Impact factor: 1.228

10.  High prevalence of HIV infection among homeless and street-involved Aboriginal youth in a Canadian setting.

Authors:  Brandon D L Marshall; Thomas Kerr; Chris Livingstone; Kathy Li; Julio S G Montaner; Evan Wood
Journal:  Harm Reduct J       Date:  2008-11-19
View more
  32 in total

Review 1.  New Solutions to Reduce Discard of Kidneys Donated for Transplantation.

Authors:  Peter P Reese; Meera N Harhay; Peter L Abt; Matthew H Levine; Scott D Halpern
Journal:  J Am Soc Nephrol       Date:  2015-09-14       Impact factor: 10.121

2.  Outcomes After Declining Increased Infectious Risk Kidney Offers for Pediatric Candidates in the United States.

Authors:  Mary G Bowring; Kyle R Jackson; Heather Wasik; Alicia Neu; Jacqueline Garonzik-Wang; Christine Durand; Niraj Desai; Allan B Massie; Dorry L Segev
Journal:  Transplantation       Date:  2019-12       Impact factor: 4.939

3.  Guidelines for the assessment and acceptance of potential brain-dead organ donors.

Authors:  Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

4.  Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.

Authors:  Christine M Durand; Samantha E Halpern; Mary G Bowring; Gilad A Bismut; Oyinkansola T Kusemiju; Brianna Doby; Reinaldo E Fernandez; Charles S Kirby; Darin Ostrander; Peter G Stock; Shikha Mehta; Nicole A Turgeon; David Wojciechowski; Shirish Huprikar; Sander Florman; Shane Ottmann; Niraj M Desai; Andrew Cameron; Allan B Massie; Aaron A R Tobian; Andrew D Redd; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-07-23       Impact factor: 8.086

5.  Utilisation of kidneys from deceased donors at increased risk of infectious disease transmission: a step in the right direction.

Authors:  Chris J Callaghan; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2019-10-30       Impact factor: 3.714

6.  Implications of declining donor offers with increased risk of disease transmission on waiting list survival in lung transplantation.

Authors:  Morgan L Cox; Michael S Mulvihill; Ashley Y Choi; Muath Bishawi; Asishana A Osho; John C Haney; Mani Daneshmand; Jacob A Klapper; Cameron R Wolfe; Matthew Hartwig
Journal:  J Heart Lung Transplant       Date:  2018-12-21       Impact factor: 10.247

7.  Consent and labeling in the use of infectious risk donor kidneys: A response to "Information Overload".

Authors:  Mary G Bowring; Allan B Massie; Macey Henderson; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-07-02       Impact factor: 8.086

8.  National Variation in Increased Infectious Risk Kidney Offer Acceptance.

Authors:  Courtenay M Holscher; Mary G Bowring; Christine E Haugen; Sheng Zhou; Allan B Massie; Sommer E Gentry; Dorry L Segev; Jacqueline M Garonzik Wang
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939

9.  Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.

Authors:  Mary G Bowring; Courtenay M Holscher; Sheng Zhou; Allan B Massie; Jacqueline Garonzik-Wang; Lauren M Kucirka; Sommer E Gentry; Dorry L Segev
Journal:  Am J Transplant       Date:  2017-12-05       Impact factor: 8.086

10.  Donor-derived infection: epidemiology and outcomes.

Authors:  Daniel R Kaul
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.